Bronchiolitis, also known as "baby virus", is an infection of the bronchi and the entire respiratory tract usually caused by Respiratory Syncytial Virus (RSV), which usually appears from November to February and is highly contagious. In adults and children it usually causes a cold, but in babies it results in bronchiolitis that usually requires hospitalization.
Professor José María Fraga, president of the Spanish Society of Perinatal Medicine, states that "Climate changes influence the epidemiology of RSV and its incidence. The predictable are modifications, both at the beginning and in the severity of the seasonal epidemic. "And climate change affects us in all areas. We have all perceived how long the summer has been done, and that we are almost in December and we still went out into the street in shirt sleeves, when years ago, at this point of autumn, we had to go with gloves, scarf and everything we had to cover ourselves from the cold. This weather prevents the scientific community from predicting the level of severity with which the virus will appear this fall and winter. Given the high incidence of last year, the concern to be prepared for new cases of bronchiolitis and respiratory syncytial virus infections this year is obvious, but for now, it is unpredictable.
The most effective way to deal with bronchiolitis or RSV is prevention, for which health professionals should be used. There are follow-up studies that indicate that the prevention of severe RSV infection with palivizumab can reduce episodes of recurrent wheezing and asthma that can occur later, as scientists agree that this virus is the main origin of these pathologies.
